Preventing skin staining: an effective iron infusion protocol.
Clinical Protocols
Coloring Agents
Extravasation of Diagnostic and Therapeutic Materials
/ prevention & control
Female
Ferric Compounds
/ administration & dosage
Health Personnel
/ education
Humans
Infusions, Intravenous
/ methods
Maltose
/ administration & dosage
Patient Education as Topic
Pregnancy
Quality Improvement
Skin
/ pathology
Clinical incident
Intravenous iron
Obstetrics
Quality improvement
Journal
International journal of health care quality assurance
ISSN: 0952-6862
Titre abrégé: Int J Health Care Qual Assur
Pays: England
ID NLM: 8916799
Informations de publication
Date de publication:
06 Mar 2020
06 Mar 2020
Historique:
entrez:
13
3
2020
pubmed:
13
3
2020
medline:
6
1
2021
Statut:
ppublish
Résumé
To implement a safe and effective intravenous iron infusion protocol to prevent skin staining. Mixed methods approach was utilised including education, auditing, self-reported survey, patient information leaflet and patient feedback. In total 25 healthcare professionals completed the survey and 15 patients provided feedback. No skin staining or severe adverse reactions were observed over eight weeks. Audit results found 53 per cent of staff were compliant with the recommended IV iron infusion protocol and 46 per cent informed patients of skin staining risk. Self-report surveys indicated 92 per cent flushed the cannula with sodium chloride before starting the infusion, 88 per cent flushed the cannula after the infusion and 76 per cent informed patients of skin staining risk. Patient feedback was largely positive and constructive. Limitations include self-reported bias, short audit time interval, missing data and discrepancy between audit and survey results. This quality improvement project was developed following two skin staining incidences at our maternity hospital. Although rare, skin staining after intravenous iron infusion is potentially permanent and may be distressing for some patients. Intravenous iron is considered safe and effective to treat anaemia during pregnancy and is often prescribed for this patient cohort. To avoid medicolegal action and patient dissatisfaction, it is essential that patients are informed of potential skin staining and an evidence-based administration protocol is utilised.
Identifiants
pubmed: 32162854
doi: 10.1108/IJHCQA-10-2019-0177
doi:
Substances chimiques
Coloring Agents
0
Ferric Compounds
0
ferric carboxymaltose
6897GXD6OE
Maltose
69-79-4
Types de publication
Journal Article
Langues
eng
Informations de copyright
© Emerald Publishing Limited.
Références
Baird-Gunning, J. and Bromley, J. (2016), “Correcting iron deficiency”, Australian Prescriber, Vol. 39 No. 6, p. 193.
Beard, J.L., Hendricks, M.K., Perez, E.M., Murray-Kolb, L.E., Berg, A., Vernon-Feagans, L., Irlam, J., Isaacs, W., Sive, A. and Tomlinson, M. (2005), “Maternal iron deficiency anemia affects postpartum emotions and cognition”, The Journal of Nutrition, Vol. 135 No. 2, pp. 267-272.
Bencaiova, G., Burkhardt, T. and Breymann, C. (2012), “Anemia—prevalence and risk factors in pregnancy”, European Journal of Internal Medicine, Vol. 23 No. 6, pp. 529-533.
Congdon, E.L., Westerlund, A., Algarin, C.R., Peirano, P.D., Gregas, M., Lozoff, B. and Nelson, C.A. (2012), “Iron deficiency in infancy is associated with altered neural correlates of recognition memory at 10 years”, The Journal of Pediatrics, Vol. 160 No. 6, pp. 1027-1033.
Daniilidis, A., Panteleris, N., Vlachaki, E., Breymann, C. and Assimakopoulos, E. (2018), “Safety and efficacy of intravenous iron administration for uterine bleeding or postpartum anaemia: a narrative review”, Journal of Obstetrics and Gynaecology, Vol. 38 No. 4, pp. 443-447.
Doellman, D., Hadaway, L., Bowe-Geddes, L.A., Franklin, M., LeDonne, J., Papke-O'Donnell, L., Pettit, J., Schulmeister, L. and Stranz, M. (2009), “Infiltration and extravasation: update on prevention and management”, Journal of Infusion Nursing, Vol. 32 No. 4, pp. 203-211.
Dougherty, L. (2008), “IV therapy: recognizing the differences between infiltration and extravasation”, British Journal of Nursing, Vol. 17 No. 14, pp. 896-901.
Froessler, B., Collingwood, J., Hodyl, N.A. and Dekker, G. (2014), “Intravenous ferric carboxymaltose for anaemia in pregnancy”, BMC Pregnancy and Childbirth, Vol. 14 No. 1, p. 115.
Gautam, C.S., Saha, L., Sekhri, K. and Saha, P.K. (2008), “Iron deficiency in pregnancy and the rationality of iron supplements prescribed during pregnancy”, The Medscape Journal of Medicine, Vol. 10 No. 12, p. 283.
Govindappagari, S. and Burwick, R.M. (2018), “Treatment of iron deficiency anemia in pregnancy with intravenous versus oral iron: systematic review and meta-analysis”, American Journal of Perinatology, Vol. 36 No. 4, pp. 366-376.
Hadaway, L. (2007), “Infiltration and extravasation”, AJN The American Journal of Nursing, Vol. 107 No. 8, pp. 64-72.
Haider, B.A., Olofin, I., Wang, M., Spiegelman, D., Ezzati, M. and Fawzi, W.W. (2013), “Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis”, British Medical Journal, Vol. 346, p. f3443.
Hermitte-Gandoliere, A., Petitpain, N., Lepelley, M., Thomas, L., Le, C.B., Astoul, J.P. and Gillet, P. (2018), “Cutaneous pigmentation related to intravenous iron extravasation: analysis from the French pharmacovigilance database”, Therapy, Vol. 73 No. 3, pp. 193-198.
Khalafallah, A.A., Dennis, A.E., Ogden, K., Robertson, I., Charlton, R.H., Bellette, J.M., Shady, J.L., Blesingk, N. and Ball, M. (2012), “Three-year follow-up of a randomised clinical trial of intravenous versus oral iron for anaemia in pregnancy”, BMJ Open, Vol. 2 No. 5, e000998.
Lim, R., Irvine, T., Ahmed, M.S., Abraham, K. and Wong, C.F. (2008), “A permanent tan from iron”, Kidney International, Vol. 73 No. 7, p. 898.
Moore, R.A., Gaskell, H., Rose, P. and Allan, J. (2011), “Meta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published trial data”, BMC Blood Disorders, Vol. 11 No. 1, p. 4.
Pavord, S., Myers, B., Robinson, S., Allard, S., Strong, J., Oppenheimer, C. and British Committee for Standards in Haematology (2012), “UK guidelines on the management of iron deficiency in pregnancy”, British Journal of Haematology, Vol. 156 No. 5, pp. 588-600.
Pérez-Pevida, B. and Kamocka, A. (2018), “Haemosiderin pigmentation after intravenous iron infusion”, BMJ: British Medical Journal (Online), Vol. 360 No. k69, p. 1.
Qassim, A., Mol, B.W., Grivell, R.M. and Grzeskowiak, L.E. (2018), “Safety and efficacy of intravenous iron polymaltose, iron sucrose and ferric carboxymaltose in pregnancy: a systematic review”, Australian and New Zealand Journal of Obstetrics and Gynaecology, Vol. 58 No. 1, pp. 22-39.
Raulin, C., Werner, S. and Greve, B. (2001), “Circumscripted pigmentations after iron injections‐treatment with Q‐switched laser systems”, Lasers in Surgery and Medicine: The Official Journal of the American Society for Laser Medicine and Surgery, Vol. 28 No. 5, pp. 456-460.
Royal College of Obstetricians and Gynaecologists (2015), Blood Transfusion in Obstetrics, Green-top Guideline No. 47, available at: https://www.rcog.org.uk/globalassets/documents/guidelines/gtg-47.pdf (accessed 4 December 2018).
Scholl, T.O. (2011), “Maternal iron status: relation to fetal growth, length of gestation, and iron endowment of the neonate”, Nutrition Reviews, Vol. 69 No. suppl_1, p. S29.
Taylor, M.J., McNicholas, C., Nicolay, C., Darzi, A., Bell, D. and Reed, J.E. (2014), “Systematic review of the application of the plan-do-study-act method to improve quality in healthcare”, BMJ Quality and Safety, Vol. 23 No. 4, pp. 290-298.
Thompson, J., Pavord, S. and Lim, K. (2014), “Severe haemosiderin pigmentation after intravenous iron infusion”, Internal Medicine Journal, Vol. 44 No. 7, pp. 706-708.